← Back
Data updated: Mar 10, 2026
ANNORA
ImmunologyNeurology
ANNORA is a generic drug manufacturer focused on Immunology, Neurology.
2019
Since
3
Drugs
-
Trials
12
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LAMIVUDINE 2025-08-20
Labeling
LAMIVUDINE 2025-08-20
Labeling
LAMIVUDINE 2025-08-20
Labeling
LAMIVUDINE 2025-08-20
Labeling
LAMIVUDINE 2025-08-20
Labeling
APREMILAST 2025-06-20
LAMIVUDINE 2025-05-08
Labeling
LAMIVUDINE 2025-05-08
Labeling
LAMIVUDINE 2025-05-08
Labeling
LAMIVUDINE 2025-03-18
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 50%
1 drugs
Neurology 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (1)
Company Info
- First Approval
- 2019-03-21
- Latest
- 2023-07-26
- Applications
- 3